Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005313704
Wed, 19.04.2023
Carl Zeiss Meditec AG
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
Jena, April 19, 2023
In the first half of fiscal year 2022/23, Carl Zeiss Meditec AG (ISIN: DE0005313704) had revenues of € 974.5 million (prior year: € 855.4 million). Operati [ … ]
Fri, 10.02.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
Weaker product mix and high investments burden development of operating profit at start of the year
JENA, 10 February 2023
Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), co [ … ]
Fri, 10.02.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23 – Orders on hand remain high
Weaker product mix and high investments burden development of operating profit at start of the year
JENA, 10 February 2023
Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), co [ … ]
Fri, 09.12.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
High revenue and strong order situation in spite of persistent geopolitical and macroeconomic risks
JENA, 9 December 2022
Carl Zeiss Meditec generated revenue of around €1,903m in fiscal year 2021/22 (prior year: €1,647m), corresponding to growth of +15.5% (adjusted [ … ]
Fri, 09.12.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec remains on growth course in fiscal year 2021/22
High revenue and strong order situation in spite of persistent geopolitical and macroeconomic risks
JENA, 9 December 2022
Carl Zeiss Meditec generated revenue of around €1,903m in fiscal year 2021/22 (prior year: €1,647m), corresponding to growth of +15.5% (adjusted [ … ]
Fri, 05.08.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
JENA, 5 August 2022
Carl Zeiss Meditec generated revenue of €1,332.9m in the first nine months of fiscal year 2021/22 (prior year: €1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with [ … ]
Fri, 05.08.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
JENA, 5 August 2022
Carl Zeiss Meditec generated revenue of €1,332.9m in the first nine months of fiscal year 2021/22 (prior year: €1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with [ … ]
Fri, 13.05.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further significant growth in revenue and order intake in first half 2021/22
Strained supply chain situation in equipment business continues
JENA, 13 May 2022
Carl Zeiss Meditec generated revenue of €855.4m in the first six months of fiscal year 2021/22 (prior year: €767.4m), corresponding to an increase of 11.5 [ … ]
Tue, 19.04.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec acquires two manufacturers of surgical instruments
Carl Zeiss Meditec announced today the acquisition of two manufacturers of surgical instruments (Kogent Surgical, LLC and Katalyst Surgical, LLC) to further strengthen its positioning as a solution provider
Jena/Germany | 19 April 2022
Kogent Surgical and Katalyst Sur [ … ]
Fri, 11.02.2022
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further growth in first quarter of 2021/22
Revenue up by around 11% year-on-year in first three months 2021/22, orders received grow by 24%
JENA, 11 February 2022
Carl Zeiss Meditec generated revenue of €410.2m in the first three months of fiscal year 2021/22 (prior year: €368.9m), corresponding to an incre [ … ]